Anthony Gregg Lapointe's Net Worth
$1.51 Million
Who is Anthony Gregg Lapointe?
Anthony Gregg Lapointe has an estimated net worth of $1.51 Million. This is based on reported shares across multiple companies, which include RIGEL PHARMACEUTICALS INC, CYTORI THERAPEUTICS, INC., Astria Therapeutics, Inc., DOR BIOPHARMA INC, ImmunoCellular Therapeutics, Ltd., QUESTCOR PHARMACEUTICALS INC, SCICLONE PHARMACEUTICALS INC, and Raptor Pharmaceutical Corp.
SEC CIK
Anthony Gregg Lapointe's CIK is 0001331860
Past Insider Trading and Trends
2009 was Anthony Gregg Lapointe's most active year for acquiring shares with 6 total transactions. Anthony Gregg Lapointe's most active month to acquire stocks was the month of May. 2017 was Anthony Gregg Lapointe's most active year for disposing of shares, totalling 9 transactions. Anthony Gregg Lapointe's most active month to dispose stocks was the month of September. 2010 saw Anthony Gregg Lapointe paying a total of $200,000.05 for 1,218,110 shares, this is the most they've acquired in one year. In 2017 Anthony Gregg Lapointe cashed out on 265,000 shares for a total of $1,506,250.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
RIGEL PHARMACEUTICALS INC (RIGL) Snapshot price: $13.32
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +33.33% | 25K |
—
|
—
| 100K |
May 25
| |||
Form 4
| +50.00% | 25K |
—
|
—
| 75K |
May 26
| |||
Form 4
| +100.00% | 25K |
—
|
—
| 50K |
May 20
| |||
Form 4
|
∞
| 25K |
—
|
—
| 25K |
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CYTORI THERAPEUTICS, INC. (PSTV) Snapshot price: $1.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Astria Therapeutics, Inc. (ATXS) Snapshot price: $11.12
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SOLIGENIX, INC. (SNGX) Snapshot price: $3.92
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| +51.25% | 25K |
$0.30 | $7,500.00 | 73.78K |
Aug 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 23
| |||
Form 4
|
∞
| 975.61K |
$0.21 | $200,000.05 | 975.61K |
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ImmunoCellular Therapeutics, Ltd. (IMUC) Snapshot price: $0.169
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||